Please Enable Cookies to Continue
Please enable cookies in your browser to experience all the personalized features of this site, including the ability to apply for a job.
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development (R&D) organization that develops and delivers new treatments for neglected diseases affecting millions of the world’s poorest people.
Together with more than 200 public research and industry allies worldwide, we use the power of partnership, innovation, open science, and advocacy to find solutions to a great injustice: the lack of medicines for life-threatening diseases that disproportionately impact poor and marginalized people. Driven by collaboration, not competition, and by patients’ needs, not profits, we promote equitable access, foster inclusive and sustainable solutions, and advocate for a more effective global biomedical R&D system that meets the needs of neglected patients.
DNDi has delivered 17 new treatments for people with sleeping sickness, visceral leishmaniasis, Chagas disease, HIV, hepatitis C, and malaria that have saved millions of lives. We aim to deliver a total of 25 new treatments by 2028– addressing R&D gaps for neglected tropical diseases and viral infections, including new pandemic-prone diseases (such as COVID-19) and climate-sensitive diseases (such as dengue) with a focus on the needs of patients in low- and middle-income countries.
With more than 240 employees of 30+ nationalities located in nine offices on four continents, DNDi is committed to diversity, equity, and inclusion as essential parts of our culture and key drivers of our success. We encourage candidates of diverse profiles and backgrounds to apply.
The system cannot access your location for 1 of 2 reasons:
- Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
- Your location information has yet to be received. Please wait a moment then hit [Search] again.
Click column header to sort
-
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV), two successful mission-driven non-for-profit Product Development Partnership organizations (PDP), have joined forces to create an innovative, shared regulatory sciences platform. This unique collaboration leverages DNDi’s broad experience in developing and registering medicines for neglected diseases with MMV’s deep malaria-specific expertise to speed up the delivery of effective, affordable and lifesaving medicines for people who need them most. The shared regulatory science platform is led by DNDi’s Director of Regulatory Sciences, with MMV’s Chief Medical Officer/Director Clinical Development serving as the anchor point on MMV’s side.
-
The Drugs for Neglected Diseases initiative (DNDi) is seeking an Executive Director to lead the organization through its next phase of impact, innovation, and sustainable growth.
DNDi is an international, not-for-profit research and development organization. Working with more than 200 public research and industry partners worldwide, we use partnership, innovation, open science, and advocacy to develop and deliver affordable and accessible treatments for neglected...
-
The Finance Manager - Grants Management is responsible for managing DNDi’s financial activities related to grant and budget management. This includes contributing to proposal development, supporting donor compliance and reporting processes, financial monitoring and ensuring compliance with DNDi policies and applicable regulations throughout the grant lifecycle.
The position also contributes to project budget planning, financial forecasting, and the effective use of budgeting tools across the organization.
The role supports program teams in the effective financial management of...
